Subscribe to AfterDawn's weekly newsletter.
Cyprotex Launches Cloe(R) Gateway, its Secure web Portal for Access to Cyprotex Services Including an Enhanced Version of Cloe(R) PK.
MACCLESFIELD, England, May 7 /PRNewswire/ -- Cyprotex today (7th May 2009) launches Cloe(R) Gateway, a new
secure web portal for access to drug discovery services. The initial offering
via Cloe(R) Gateway is a new enhanced version of our proprietary predictive
software, Cloe(R) PK, which predicts whole body pharmacokinetics from simple
in vitro ADME and physicochemical properties.
Commenting on the launch, Dr Anthony D. Baxter, Cyprotex's
Chief Executive Officer, said:
"I am delighted to announce the launch of our new and novel
web portal Cloe(R) Gateway and its first product, an improved version of
Cloe(R) PK. Cloe(R) PK, as a server based product, has been used by many of
our customers for prediction of pharmacokinetic properties from early ADME
data and found it to be very useful in decision making for candidate
selection. Cyprotex have invested considerable time and effort improving the
Cloe(R) PK model and we are proud to launch version 2.1 as an online service
available via Cloe(R) Gateway. This will enable many more of our customers to
utilise this excellent product on a simple pay-per-use model. The cost
effectiveness of this approach will allow access of such predictive
technologies to new audiences of scientists such as bench medicinal chemists.
This approach to selling software solutions is new to the ADME /
pharmacokinetic world and we anticipate it will grow to replace competitor
products still being sold on the outdated server / license model.
The pharmaceutical industry has amassed a huge quantity of
ADME data over the past few years and the availability of an online version
of Cloe(R) PK though Cloe(R) Gateway will enable those companies to realise
tremendous real added value from that data in the form of pharmacokinetic
performance characteristics to enable faster, cheaper and better designed
drugs to be developed.
I look forward to announcing further new products to be sold
through Cloe(R) Gateway such as a human intestinal absorption model and a
product to enable customers to access our largest selling product Cloe(R)
Screen in the near future."
For further information:
Cyprotex PLC
Helen Gill PhD, Product Development Manager
Tel: +44(0)1625-505-100
h.gill@cyprotex.com
http://www.cyprotex.com
